All published articles of this journal are available on ScienceDirect.
COVID-19 and HIV-associated Nephropathies: Double Whammy
Abstract
The number of COVID-19-associated nephropathies (COVAN) rapidly increased before the fourth wave of the COVID-19 pandemic. Similarities and common lesions with the HIV-associated nephropathy (HIVAN) remarkably affect mostly African Americans positive for the APOL1 risk variants; therefore, these cases must be prioritized in new targeted clinical trials.